Inhaler return to pharmacies part of updated NHS ‘Green plan guidance’ The updated guidance encourages trusts and other NHS organisations to renew their sustainability plans for the next three-year cycle in order to help achieve NHS net zero carbon emissions.…
Third of asthma inhalers without dose counters returned for recycling when half full, study finds Researchers found that inhalers with dose counters were much more likely to be returned empty (51.3%) compared with those without counters (25.1%).…
First UK-wide joint asthma guideline recommends combination treatment for new diagnoses The guideline recommends that all asthma patients over the age of 12 should be prescribed low dosages of inhaled corticosteroids and formoterol to address inflammation and symptoms.…
Pharmacy initiative results in 300% increase in inhalers being returned for sustainable disposal Five pharmacies in and around Edinburgh spent ten weeks adding stickers to dispensing bags to encourage patients to return inhalers to the pharmacy.…
Bringing high-quality diagnostics for COPD and asthma to north Wales As a pharmacist prescriber at a community diagnostic respiratory hub in South Denbighshire, North Wales, Kevin Parvin explains why the hub is needed and how it is benefiting patients.…
More than 20,000 inhalers returned since November 2023 through recycling pilot Exclusive: Since its launch in November 2023, 20,400 inhalers have been returned through the ‘Re-Hale’ scheme, which operates across 78 locations in East Kent.…
Joint guidance for asthma recommends replacing SABA with corticosteroid inhalers The draft guidance proposes the use of combined inhaled corticosteroid/formoterol inhalers over previously preferred short-acting beta agonists.…
Greener inhaler propellant is therapeutically equivalent to traditional alternatives, study results suggest Study authors reported overall bioequivalence between inhalers that use HFA-152a as a propellant and traditionally used devices with HFA-134a as a propellant.…
‘Unresolvable conflict’: are links to big tobacco changing inhaler prescribing? The takeover of inhaler company Vectura by tobacco firm Philip Morris International has stirred up debate and controversy, with experts raising questions around whether the NHS is doing enough to make the connection clear to prescribers and patients.…
NHS spends £430m on inhalers linked to Philip Morris since Vectura takeover Exclusive: An analysis by The Pharmaceutical Journal of prescribing data has raised questions from experts on whether more should be done to highlight the inhalers‘ links to the tobacco company.…
